Committed Capital Sidecar | PREP Act Liability Immunity: Considerations for PE Portfolio Companies During COVID-19
May 24, 2021
“Committed Capital Sidecar” is a new, bite-sized feature within our Committed Capital podcast series which quickly covers a key development affecting the private equity industry.
What should private equity industry players know about the Public Readiness and Emergency Preparedness (“PREP”) Act? In our third Sidecar episode, product liability and mass torts partner Sara Roitman and associate Monica Gorny discuss the broad liability immunity the Act provides to companies involved in COVID-19 diagnosis, treatment and prevention activities, as well as how it may reduce litigation risk for PE portfolio companies working to address the global pandemic.
